The setup in the social media giant has yet to trigger, but the mining company already has signaled go.
Tons of liquidity plus rising commodity and labor costs are likely to put inflation back in the lexicon of investors once again.
It's Five Below, which offers tons of stuff to help meet post-pandemic, pent-up demand for fun.
Evidence of rising prices is everywhere; the big question is whether this surge is a blip or a something that will get out of hand.
Following both for potential buy setups.
Volume has picked up dramatically since a selloff in the online health services provider began, and it could get worse.
Berry Global and Griffon Corp. are two underappreciated companies that still look cheap based on their growth prospects.
Trillium Therapeutics and Provention Bio have products in the pipeline that could propel their shares upward.
The stock of the social media platform has doubled in the last six months, but the future direction of the shares is a concern based on its chart.
Microsoft and Abbott Laboratories are the names that are worth watching.